Have the New Pulmonary Hypertension Drugs Changed the Game?
Med Page Today
DECEMBER 29, 2024
(MedPage Today) -- In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both combination macitentan/tadalafil.
Let's personalize your content